BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36754326)

  • 1. Prediction of pharmaceuticals removal in activated sludge system under different operational parameters using an extended ASM-PhACs model.
    Li X; Lei S; Wu G; Yu Q; Xu K; Ren H; Wang Y; Geng J
    Sci Total Environ; 2023 May; 871():162065. PubMed ID: 36754326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model-based assessment of estrogen removal by nitrifying activated sludge.
    Peng L; Dai X; Liu Y; Sun J; Song S; Ni BJ
    Chemosphere; 2018 Apr; 197():430-437. PubMed ID: 29360597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing the removal routes of seven pharmaceuticals in the activated sludge process.
    Peng J; Wang X; Yin F; Xu G
    Sci Total Environ; 2019 Feb; 650(Pt 2):2437-2445. PubMed ID: 30292999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotransformation of pharmaceuticals under nitrification, nitratation and heterotrophic conditions.
    Fernandez-Fontaina E; Gomes IB; Aga DS; Omil F; Lema JM; Carballa M
    Sci Total Environ; 2016 Jan; 541():1439-1447. PubMed ID: 26479917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the removal of pharmaceuticals and personal care products in a full-scale activated sludge plant.
    Salgado R; Marques R; Noronha JP; Carvalho G; Oehmen A; Reis MA
    Environ Sci Pollut Res Int; 2012 Jun; 19(5):1818-27. PubMed ID: 22207237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The characteristics of enriched nitrifier culture in the degradation of selected pharmaceutically active compounds.
    Tran NH; Urase T; Kusakabe O
    J Hazard Mater; 2009 Nov; 171(1-3):1051-7. PubMed ID: 19615816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of sorption processes in the removal of pharmaceuticals by fungal treatment of wastewater.
    Lucas D; Castellet-Rovira F; Villagrasa M; Badia-Fabregat M; Barceló D; Vicent T; Caminal G; Sarrà M; Rodríguez-Mozaz S
    Sci Total Environ; 2018 Jan; 610-611():1147-1153. PubMed ID: 28847135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of advanced biological treatment and nature-based solutions for the treatment of pharmaceutically active compounds (PhACs): A comprehensive study for wastewater and sewage sludge.
    Nas B; Dolu T; Argun ME; Yel E; Ateş H; Koyuncu S
    Sci Total Environ; 2021 Jul; 779():146344. PubMed ID: 34030227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.
    Radjenović J; Petrović M; Barceló D
    Water Res; 2009 Feb; 43(3):831-41. PubMed ID: 19091371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitrosation and nitration of diclofenac and structurally related nonsteroidal anti-inflammatory drugs (NSAIDs) in nitrifying activated sludge.
    Osorio V; Cruz-Alcalde A; Pérez S
    Sci Total Environ; 2022 Feb; 807(Pt 1):150533. PubMed ID: 34597575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution and Removal of Pharmaceuticals in Liquid and Solid Phases in the Unit Processes of Sewage Treatment Plants.
    Park J; Kim C; Hong Y; Lee W; Chung H; Jeong DH; Kim H
    Int J Environ Res Public Health; 2020 Jan; 17(3):. PubMed ID: 31973074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatial distribution of pharmaceuticals in conventional wastewater treatment plant with Sludge Treatment Reed Beds technology.
    Kołecka K; Gajewska M; Stepnowski P; Caban M
    Sci Total Environ; 2019 Jan; 647():149-157. PubMed ID: 30077845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upflow anaerobic sludge blanket reactor--a review.
    Bal AS; Dhagat NN
    Indian J Environ Health; 2001 Apr; 43(2):1-82. PubMed ID: 12397675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fate of diclofenac in municipal wastewater treatment plant - a review.
    Vieno N; Sillanpää M
    Environ Int; 2014 Aug; 69():28-39. PubMed ID: 24791707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodegradation of Emerging Pharmaceuticals from Domestic Wastewater by Membrane Bioreactor: The Effect of Solid Retention Time.
    Alobaidi RAK; Ulucan-Altuntas K; Mhemid RKS; Manav-Demir N; Cinar O
    Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33805955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation of PPCPs in activated sludge from different WWTPs in Denmark.
    Chen X; Vollertsen J; Nielsen JL; Dall AG; Bester K
    Ecotoxicology; 2015 Dec; 24(10):2073-80. PubMed ID: 26407712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodegradation and Metabolism of Tetrabromobisphenol A (TBBPA) in the Bioaugmented Activated Sludge Batch Bioreactor System by Heterotrophic and Nitrifying Bacteria.
    Islam MS; Zhou H; Zytner RG
    Water Environ Res; 2018 Feb; 90(2):122-128. PubMed ID: 29348000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodegradation of ibuprofen, diclofenac and carbamazepine in nitrifying activated sludge under 12 °C temperature conditions.
    Kruglova A; Ahlgren P; Korhonen N; Rantanen P; Mikola A; Vahala R
    Sci Total Environ; 2014 Nov; 499():394-401. PubMed ID: 25215408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling the biotransformation of trimethoprim in biological nutrient removal system.
    Ogunlaja OO; Parker WJ
    Water Sci Technol; 2017 Apr; 2017(1):144-155. PubMed ID: 29698230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodegradation of pharmaceuticals in hospital wastewater by a hybrid biofilm and activated sludge system (Hybas).
    Escolà Casas M; Chhetri RK; Ooi G; Hansen KMS; Litty K; Christensson M; Kragelund C; Andersen HR; Bester K
    Sci Total Environ; 2015 Oct; 530-531():383-392. PubMed ID: 26057543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.